Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Verona Pharma Plc ADR shares valued at $2,254,320 were sold by ZACCARDELLI DAVID on Sep 11 ’24. At $3.76 per share, ZACCARDELLI DAVID sold 600,000 shares. The insider’s holdings dropped to 15,250,704 shares worth approximately $478.41 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hahn Mark W sold 600,000 shares, netting a total of over 2,254,080 in proceeds. Following the sale of shares at $3.76 each, the insider now holds 14,339,688 shares.
Before that, MARK HAHN had added 75,000 shares to its account. In a trade valued at $2,103,000, the Officer bought Verona Pharma Plc ADR shares for $28.04 each.
As published in their initiating research note from Wells Fargo on October 03, 2024, Verona Pharma Plc ADR [VRNA] has been an Overweight and the price target has been revised to $50. Earlier on August 26, 2022, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for VRNA stock.
Analyzing VRNA Stock Performance
During the last five days, there has been a surge of approximately 1.82%. Over the course of the year, Verona Pharma Plc ADR shares have jumped approximately 57.80%. Shares of the company reached a 52-week high of $32.88 on 10/04/24 and a 52-week low of $11.39 on 05/30/24. A 50-day SMA is recorded $27.50, while a 200-day SMA reached $19.39. Nevertheless, trading volume fell to 0.47 million shares from 0.84 million shares the previous day.
Support And Resistance Levels for Verona Pharma Plc ADR (VRNA)
According to the 24-hour chart, there is a support level at 30.93, which, if violated, would cause prices to drop to 30.49. In the upper region, resistance lies at 32.00. The next price resistance is at 32.64. RSI (Relative Strength Index) is 63.56 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.62, which suggests the price will increase in the coming days. Percent R is at 28.28%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Verona Pharma Plc ADR (VRNA)?
On September 13, 2021, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $25.
